-
Charlie Puth and Ellie Goulding to Headline First Johnnie & Co. Festival in Mumbai
-
ALIX LASERS shareholders remove Michael Sobitsch as managing director in view of the circumstances
-
Maryland Woman Arrested in Decade-Long Cancer Scam Involving Fake Medical Team
-
Panthers Seek NFC South Lead Against Ravens as Baltimore Ends Skid
-
Dateline appoints Tony Ferguson as Acting Chairman
-
American Businessman Mark Eric Williams Vindicated in Six-Year, US$150 Million-Plus Litigation Brought by Kuwaiti State Entities
-
AI Search Engineers Says Longer AI Mode Questions Mean Professional Service Firms Should Answer Full Client Questions Directly on Their Pages
-
Arrive AI's Pro Forma Stockholders' Equity Now Above Nasdaq Minimum Requirement Following Recent Transactions
-
Who Does the Best Rhinoplasty in Sarasota?
-
PodcastOne (NASDAQ:PODC) Launches People Pleasers Podcast hosted by Comedians Leah Rudick and Jessica Michelle Singleton
-
Alset AI Closes Non-Brokered Private Placement Offering
-
Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
-
barq Signs MoU with TenPay Global to Enhance Remittances and Digital Payments in China
-
American Resources Corporation and ReElement Technologies Selected as Part of Winning U.S.-Led Consortium for Kenya's Strategic Mrima Hill Critical Minerals Project
-
Ryde Group Ltd Announces Non-Binding Term Sheet for Proposed Minority Investment in Multi Genius Limited and MOU on Technology Collaboration
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 20
-
Tosca's 2026 Sustainability Report Makes the Case for Packaging as Critical Supply Chain Infrastructure
-
The DEA Laid The Trap - And State Marijuana Operators Took The Bait
-
5 Fun Date Night Ideas That Don't Cost a Fortune
-
AsiaFIN Holdings Corp. Appoints Fortune Angel INC as U.S. Reseller Partner to Expand Its Agentic and Robotic Process Automation SaaS Business Across New York and the East Coast
-
What Is the Best Social Media Platform for Peptides?
-
WhalesBot Advances Creativity-Driven AI and Coding Education Through Pubbo AI
-
Karviva Introduces Unwined Alcohol-Free Malbec and Rose Varieties
-
Tidal Wave Auto Spa Opens New Locations in Murfreesboro, Tennessee and Asheville, North Carolina This Week
-
Peoples Bancorp Announces Cash Dividend
-
Jaguar Health, Inc. Announces Reverse Stock Split
-
Kartoon Studios' Beacon Media Partners With Bandai on Tamagotchi's Landmark 30th Anniversary Times Square Celebration
-
First Phosphate and Zeo Energy Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
enVVeno Medical Presents Three-Year Surgical Venous Valve Replacement Data Showing Sustained Clinical Benefit and Highlights Next-Generation enVVe Transcatheter System at the 53rd Annual VEITH Symposium
-
Taylor Bank Announces $125,000 Commitment to Diakonia's Supportive Living Campus Capital Campaign
-
Ondas, Palantir and Regna AI Host Key Defense Technology Leaders to Accelerate the Path from AI Innovation to Fielded Capability
-
Cytta Air Expands Military Contracting Expertise - Appoints Rear Admiral James "Gib" Godwin III to Advisory Board
-
Closing a Business with Payroll Taxes Owed - Clear Start Tax Explains the Trust Fund Recovery Penalty
-
Commonhold Explained: How New Leasehold Ban Changes Property Ownership in England and Wales
-
Factory Worker Dies in Rare Rectal Explosion Incident in Czechia
-
GIRLBAND! Headline Show at Rough Trade Marks National Breakthrough
-
Decoding UNFCCC Legal Language: The Hierarchy of Verbs in Climate Negotiations
From DEA Marijuana Regulator to Consultant: How DEA Retired Administrators Are Now Profiting from the Mess They Created
WASHINGTON, DC / ACCESS Newswire / October 23, 2025 / Matthew Strait, the longtime architect of the DEA's failed marijuana manufacturing policies, has reemerged in the private sector under a new banner - Controlled Substance Strategies. The company's mission statement promises to help clients "cut through complexity, stay compliant, and achieve strategic goals."
But behind that polished language lies a striking irony: Strait himself was one of the key officials responsible for creating that complexity in the first place.
DEA Matthew Strait, The Architect of Obstruction

As DEA's Deputy Assistant Administrator for the Diversion Control Division, Strait was responsible for overseeing the agency's licensing and quota programs - including the process for approving companies to manufacture Schedule I substances such as cannabis for scientific and medical research.
Under his watch, the DEA turned what should have been a transparent, time-limited licensing process into a seven-year bureaucratic quagmire that crippled innovation and left patients without access to federally approved cannabinoid medicines.
Companies like MMJ BioPharma Cultivation, which has FDA authorizations and Orphan Drug designations to produce cannabis-derived medicines for Huntington's disease and Multiple Sclerosis, were trapped in endless regulatory limbo while DEA insiders rewrote rules retroactively, shifting requirements mid-stream.
"Matthew Strait creates the problem, now he wants to profit from unraveling his own mess, stated Duane Boise CEO of MMJ.
The Bureaucrat-to-Consultant Pipeline
Strait's new firm - Controlled Substance Strategies - bills itself as a guide for pharmaceutical manufacturers, prescribers, and researchers trying to navigate federal controlled-substance law. It advertises expertise in "quota optimization," "DEA compliance," and even "research with Schedule I controlled substances."
Yet every issue the company claims to solve - licensing backlogs, conflicting policy, outdated regulations - originated inside the very DEA office Strait helped run.
In other words, the same officials who blocked legitimate science for years are now marketing themselves as private-sector "problem solvers."
This revolving-door pattern isn't just bad optics - it raises serious ethical and policy questions about the integrity of federal drug regulation.
Collateral Damage: Patients and Science
While Strait and his former colleagues reinvent their careers, patients continue to suffer. The DEA's failure to process research registrations on time has delayed critical FDA-approved trials for multiple sclerosis and Huntington's disease. Meanwhile, illegal marijuana grows, many financed by foreign criminal networks, have proliferated across the country - unimpeded by the same DEA that claimed to be protecting public health.
The result: a system that blocks scientists while rewarding smugglers.
Accountability Must Come Before Consulting
Congress and the courts are now unraveling the consequences of this bureaucratic misconduct. The Department of Justice's withdrawal of its defense for DEA's in-house tribunal system underscores the constitutional rot that took root under Milgram, Prevoznik, and Strait.
"Until there's accountability for what these people did while in power, no one should be profiting from that legacy," Boise said. "The DEA's obstruction isn't a consulting opportunity - it's a crime scene."
The Bottom Line
Matthew Strait's Controlled Substance Strategies is a masterclass in Washington doublespeak: a firm that claims to help fix the very system its founder broke.
For patients, scientists, and legitimate pharmaceutical developers, it's a reminder that the real work of reform isn't in consultancy - it's in accountability.
MMJ is represented by attorney Megan Sheehan
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
View the original press release on ACCESS Newswire
O.Ortiz--AT